3 results loaded, newest first. End of these results.
News 2026-10-16 05:08 UTC
Oct 16 (Reuters) — POLYPEPTIDE GROUP AG: Definitive Interim Result Of The Public Tender Offer Of Samsung Biologics Co., Ltd. Samsung Peptide Holds 87.92% Of Polypeptide Share Capital 87.59% Of Polypeptide Shares Tendered Into Offer Minimum Acceptance Rate Condition Of Offer Satisfied No Material Adverse Effect Conditio
News 2026-10-16 05:03 UTC
PolyPeptide Group / Key word(s): Tender Offer PolyPeptide Group: Definitive interim result of the public tender offer of Samsung Biologics Co., Ltd. 16-Oct-2026 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. ══════════════
News 2026-10-13 05:10 UTC
PolyPeptide Group / Key word(s): Tender Offer PolyPeptide Group: Provisional interim result of the public tender offer of Samsung Biologics Co., Ltd. 13-Oct-2026 / 07:10 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. ═════════════